Precision BioSciences
Precision is a North Carolina-based biotechnology firm that develops and commercializes immuno-oncology therapeutics for the treatment of cancer.
Business Model:
Revenue: $20.8M
Employees: 51-200
Industries / Tags:
Detailed Precision BioSciences Information
Geographic Data
Address: 302 East Pettigrew Street
City: Durham
State: NC
Zip: 27701
Country: US
Financial Info
Stage:
post ipo equity
Raised Last:
$50M
Raised Total:$225M
Social
Metrics
1,316,378Website Global Rank
21,773Website Monthly Traffic
Twitter Followers
Description
Precision is a North Carolina-based biotechnology firm that develops and commercializes immuno-oncology therapeutics for the treatment of cancer.
Contact Phone:
+19193145512
Contact Email:
Precision BioSciences went public on 3/27/2019 on the NASDAQ
Listed Exchange:
NASDAQ
IPO Date:
3/27/2019
IPO Valuation:
$784M
Ticker Symbol:
DTIL
IPO Price:
$16/share
Amount Raised:
$126M
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
